Heroin or cocaine addictions are major public health problems, with massive biomedical and societal costs. The onset of these addictive states is characterized by cycles of repeated exposure to the drug of abuse, followed by withdrawal/abstinence and re-exposure. Therefore these cycles may be cardinal features of addictions as chronic relapsing disorders. Persisting adaptations in endogenous opioid neuropeptide and opioid receptor systems (e.g., prodynorphin [Pdyn], MOP-r and KOP-r) in dopaminergic nigrostriatal and meso-limbic pathways occur as a result of exposure to heroin or cocaine, as well as withdrawal therefrom. It is hypothesized that these neurobiological changes underlie the increased propensity to self-administer drugs, or increased propensity to escalate such self-administration upon re-exposure. The neurobiological effects of a standardized cycle of chronic exposure, withdrawal and re-exposure cannot be directly studied in humans, and have not been systematically studied in experimental animals. Thus, the main objective of this project is to determine dynamic neurobiological changes (at the mRNA and protein level in the aforementioned and related target systems) in rats at specific stages in a cycle of chronic (14-day) escalating exposure to heroin or cocaine, followed by long term (14-day) withdrawal and chronic (14-day) re-exposure to the drug of abuse, modeling the neurobiological consequences of an addiction-like cycle (Aim 1). Parallel studies would define changes to reward-related functions of heroin or cocaine (in self-administration and conditioned place preference assays) that occur at defined stages of exposure, withdrawal and re-exposure (Aims 2 and 3). Further studies in mice would determine analogous changes in this addiction-like cycle, also with respect to critical neurochemical effects of heroin, cocaine and opioid neuropeptides on dopamine levels in terminal fields of these dopaminergic pathways (Aim 4). Targeted gene """"""""knockdown"""""""" with RNA interference using siRNAs specific for MOP-r or Pdyn will be directed toward areas containing cell bodies of the above pathways, either prior to chronic exposure, or at the onset of withdrawal (Aim 5). These siRNA studies will determine whether """"""""knockdown"""""""" interventions can block neurobiological, neurochemical or reward-related behavioral changes occurring at specific stages of the addiction-like cycle to heroin or cocaine. Locally administered pharmacological probes (e.g., opioid receptor antagonists) will be used to confirm potential pharmacotherapeutic approaches mechanistically identified with siRNA knockdown. This proposal would determine neurobiological changes underlying an addiction-like cycle of exposure, withdrawal and re-exposure to heroin or cocaine, and will identify targets for pharmacotherapeutic intervention in such stages. For synergy, studies in this Project (Aim 1) will use parallel methodology with Project 2 (Aim 2) of this Center (and will focus on the influence of stress-responsive systems in this setting).

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Comprehensive Center (P60)
Project #
5P60DA005130-23
Application #
7848963
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
23
Fiscal Year
2009
Total Cost
$268,013
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Gasser, Paul J; Hurley, Matthew M; Chan, June et al. (2017) Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct 222:1913-1928
Butelman, Eduardo Roque; Bacciardi, Silvia; Maremmani, Angelo Giovanni Icro et al. (2017) Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity? Am J Addict 26:632-639
Valenza, Marta; Picetti, Roberto; Yuferov, Vadim et al. (2016) Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration. Neuropharmacology 105:639-650
Garzón, Miguel; Pickel, Virginia M (2016) Electron microscopic localization of M2-muscarinic receptors in cholinergic and noncholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei of the rat mesopontine tegmentum. J Comp Neurol 524:3084-103
Zhou, Yan; Leri, Francesco; Cummins, Erin et al. (2015) Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats. Physiol Behav 139:127-35
Zhou, Y; Kreek, M J (2015) Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic ""binge"" pattern escalating-dose, but not steady-dose, cocaine. Neuroscience 289:63-70
Zhou, Yan; Kreek, Mary Jeanne (2014) Alcohol: a stimulant activating brain stress responsive systems with persistent neuroadaptation. Neuropharmacology 87:51-8
Mayer-Blackwell, B; Schlussman, S D; Butelman, E R et al. (2014) Self administration of oxycodone by adolescent and adult mice affects striatal neurotransmitter receptor gene expression. Neuroscience 258:280-91
Garzón, Miguel; Pickel, Virginia M (2013) Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission. J Comp Neurol 521:2927-46
Levran, Orna; Peles, Einat; Randesi, Matthew et al. (2013) Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics 14:755-68

Showing the most recent 10 out of 168 publications